Sept. 28, 2018 — The Drug Enforcement Administration (DEA) has reclassified the epilepsy cannabidiol drug Epidiolex from Schedule I to Schedule V,…
Sept. 28, 2018 — The Drug Enforcement Administration (DEA) has reclassified the epilepsy cannabidiol drug Epidiolex from Schedule I to Schedule V,…
